Kezar Life Sciences, Inc.KZREarnings & Financial Report
Nasdaq
KZR Q3 2024 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-21.9M
Net Profit
$-20.3M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-2.78
Kezar Life Sciences, Inc. Q3 2024 Financial Summary
Kezar Life Sciences, Inc. reported revenue of $0 for Q3 2024, with a net profit of $-20.3M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-20.3M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2024 |
Income Statement
| Q3 2022 | Q3 2023 | Q3 2024 | |
|---|---|---|---|
| Revenue | $0 | $7.0M | $0 |
| YoY Growth | N/A | N/A | N/A |
Balance Sheet
| Q3 2022 | Q3 2023 | Q3 2024 | |
|---|---|---|---|
| Assets | $304.8M | $249.3M | $164.1M |
| Liabilities | $21.6M | $33.3M | $30.0M |
| Equity | $283.2M | $216.0M | $134.0M |
Cash Flow
| Q3 2022 | Q3 2023 | Q3 2024 | |
|---|---|---|---|
| Operating CF | $-16.4M | $-20.2M | $-17.5M |